Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Weiner, HL
   The fine line between autoimmune and allergic encephalomyelitis
   NATURE IMMUNOLOGY
   
   H.L. Weiner, "The fine line between autoimmune and allergic encephalomyelitis", NAT IMMUNOL, 2(3), 2001, pp. 193-194
2. Carruthers, D; Bacon, P
   Activity, damage and outcome in systemic vasculitis
   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
   
   D. Carruthers e P. Bacon, "Activity, damage and outcome in systemic vasculitis", BEST PR R C, 15(2), 2001, pp. 225-238
3. Langford, CA
   Management of systemic vasculitis
   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
   
   C.A. Langford, "Management of systemic vasculitis", BEST PR R C, 15(2), 2001, pp. 281-297
4. Bacon, PA; Carruthers, D
   New therapeutic aspects: haemopoietic stem cell transplantation
   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
   
   P.A. Bacon e D. Carruthers, "New therapeutic aspects: haemopoietic stem cell transplantation", BEST PR R C, 15(2), 2001, pp. 299-313
5. Girard, T; Mahr, A; Noel, LH; Cordier, JF; Lesavre, P; Andre, MH; Guillevin, L
   Are antineutrophil cytoplasmic antibodies a marker predictive of relapse in Wegener's granulomatosis? A prospective study
   RHEUMATOLOGY
   
   T. Girard et al., "Are antineutrophil cytoplasmic antibodies a marker predictive of relapse in Wegener's granulomatosis? A prospective study", RHEUMATOLOG, 40(2), 2001, pp. 147-151
6. Endre, Z
   Treatment of lupus nephritis: art or science?
   INTERNAL MEDICINE JOURNAL
   
   Z. Endre, "Treatment of lupus nephritis: art or science?", INTERN M J, 31(5), 2001, pp. 264-266
7. Illei, GG; Czirjak, L
   Novel approaches in the treatment of lupus nephritis
   EXPERT OPINION ON INVESTIGATIONAL DRUGS
   
   G.G. Illei e L. Czirjak, "Novel approaches in the treatment of lupus nephritis", EXPERT OP I, 10(6), 2001, pp. 1117-1130
8. Khan, OA; Zvartau-Hind, M; Caon, C; Din, MU; Cochran, M; Lisak, D; Tselis, AC; Kamholz, JA; Garbern, JY; Lisak, RP
   Effect of monthly intravenous cyclophosphamide in rapidly deteriorating multiple sclerosis patients resistant to conventional therapy
   MULTIPLE SCLEROSIS
   
   O.A. Khan et al., "Effect of monthly intravenous cyclophosphamide in rapidly deteriorating multiple sclerosis patients resistant to conventional therapy", MULT SCLER, 7(3), 2001, pp. 185-188
9. Foltz, V; Koeger, AC; de Sauverzac, C; de Person, JF; Bourgeois, P; Fautrel, B
   Relapse of Wegener's granulomatosis. Concerning a case after 20 years of remission
   JOINT BONE SPINE
   
   V. Foltz et al., "Relapse of Wegener's granulomatosis. Concerning a case after 20 years of remission", JOINT BONE, 68(3), 2001, pp. 262-266
10. Specks, U
    Diffuse alveolar hemorrhage syndromes
    CURRENT OPINION IN RHEUMATOLOGY
    
    U. Specks, "Diffuse alveolar hemorrhage syndromes", CURR OP RH, 13(1), 2001, pp. 12-17
11. Jayne, D
    Update on the European Vasculitis Study Group trials
    CURRENT OPINION IN RHEUMATOLOGY
    
    D. Jayne, "Update on the European Vasculitis Study Group trials", CURR OP RH, 13(1), 2001, pp. 48-55
12. Mosca, M; Neri, R; Giannessi, S; Pasquariello, A; Puccini, R; Bencivelli, W; Bombardieri, S
    Therapy with pulse methylprednisolone and short course pulse cyclophosphamide for diffuse proliferative glomerulonephritis
    LUPUS
    
    M. Mosca et al., "Therapy with pulse methylprednisolone and short course pulse cyclophosphamide for diffuse proliferative glomerulonephritis", LUPUS, 10(4), 2001, pp. 253-257
13. Takada, K; Illei, GG; Boumpas, DT
    Cyclophosphamide for the treatment of systemic lupus erythematosus
    LUPUS
    
    K. Takada et al., "Cyclophosphamide for the treatment of systemic lupus erythematosus", LUPUS, 10(3), 2001, pp. 154-161
14. Wallace, DJ
    Apheresis for lupus erythematosus: state of the art
    LUPUS
    
    D.J. Wallace, "Apheresis for lupus erythematosus: state of the art", LUPUS, 10(3), 2001, pp. 193-196
15. Adu, D
    The evidence base for the treatment of lupus nephritis in the new millennium
    NEPHROLOGY DIALYSIS TRANSPLANTATION
    
    D. Adu, "The evidence base for the treatment of lupus nephritis in the new millennium", NEPH DIAL T, 16(8), 2001, pp. 1536-1538
16. de Groot, K; Adu, D; Savage, COS
    The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review
    NEPHROLOGY DIALYSIS TRANSPLANTATION
    
    K. de Groot et al., "The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review", NEPH DIAL T, 16(10), 2001, pp. 2018-2027
17. Boumpas, DT
    Lupus nephritis
    NEPHROLOGY DIALYSIS TRANSPLANTATION
    
    D.T. Boumpas, "Lupus nephritis", NEPH DIAL T, 16, 2001, pp. 55-57
18. Latta, K; von Schnakenburg, C; Ehrich, JHH
    A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children
    PEDIATRIC NEPHROLOGY
    
    K. Latta et al., "A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children", PED NEPHROL, 16(3), 2001, pp. 271-282
19. Esnault, VLM
    Treatment of vascularides with antineutrophil cytoplasmic autoantibodies
    PRESSE MEDICALE
    
    V.L.M. Esnault, "Treatment of vascularides with antineutrophil cytoplasmic autoantibodies", PRESSE MED, 30(22), 2001, pp. 1122-1125
20. Korman, NJ
    New immunomodulating drugs in autoimmune blistering diseases
    DERMATOLOGIC CLINICS
    
    N.J. Korman, "New immunomodulating drugs in autoimmune blistering diseases", DERM CLIN, 19(4), 2001, pp. 637
21. Silvis, NG
    Antimetabolites and cytotoxic drugs
    DERMATOLOGIC CLINICS
    
    N.G. Silvis, "Antimetabolites and cytotoxic drugs", DERM CLIN, 19(1), 2001, pp. 105
22. Jayne, D
    Clinical management and treatment of vasculitis
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY
    
    D. Jayne, "Clinical management and treatment of vasculitis", SPR SEM IMM, 23(3), 2001, pp. 267-286
23. Carruthers, D; Bacon, P
    Combination therapy in autoimmune disease: vasculitis
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY
    
    D. Carruthers e P. Bacon, "Combination therapy in autoimmune disease: vasculitis", SPR SEM IMM, 23(1-2), 2001, pp. 91-108
24. Buratti, S; Szer, IS; Spencer, CH; Bartosh, S; Reiff, A
    Mycophenolate mofetil treatment of severe renal disease in pediatric onsetsystemic lupus erythematosus
    JOURNAL OF RHEUMATOLOGY
    
    S. Buratti et al., "Mycophenolate mofetil treatment of severe renal disease in pediatric onsetsystemic lupus erythematosus", J RHEUMATOL, 28(9), 2001, pp. 2103-2108
25. de Groot, K; Gross, WL; Herlyn, K; Reinhold-Keller, E
    Development and validation of a disease extent index for Wegener's granulomatosis
    CLINICAL NEPHROLOGY
    
    K. de Groot et al., "Development and validation of a disease extent index for Wegener's granulomatosis", CLIN NEPHR, 55(1), 2001, pp. 31-38
26. Mok, CC; Ho, CTK; Siu, YP; Chan, KW; Kwan, TH; Lau, CS; Wong, RWS; Au, TC
    Treatment of diffuse proliferative lupus glomerulonephritis: A comparison of two cyclophosphamide-containing regimens
    AMERICAN JOURNAL OF KIDNEY DISEASES
    
    C.C. Mok et al., "Treatment of diffuse proliferative lupus glomerulonephritis: A comparison of two cyclophosphamide-containing regimens", AM J KIDNEY, 38(2), 2001, pp. 256-264
27. Zimmerman, R; Radhakrishnan, J; Valeri, A; Appel, G
    Advances in the treatment of lupus nephritis
    ANNUAL REVIEW OF MEDICINE
    
    R. Zimmerman et al., "Advances in the treatment of lupus nephritis", ANN R MED, 52, 2001, pp. 63-78
28. Julkunen, H
    Pregnancy and lupus nephritis
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
    
    H. Julkunen, "Pregnancy and lupus nephritis", SC J UROL N, 35(4), 2001, pp. 319-327
29. Uriel, MG; Roc, MV; Marques, AO
    A review of systemic necrotizing vasculitis and giant cell arteritis: the importance of severity
    MEDICINA CLINICA
    
    M.G. Uriel et al., "A review of systemic necrotizing vasculitis and giant cell arteritis: the importance of severity", MED CLIN, 117(5), 2001, pp. 191-195
30. Fraenkel, L; Bodardus, S; Wittink, DR
    Understanding patient preferences for the treatment of lupus nephritis with Adaptive Conjoint Analysis
    MEDICAL CARE
    
    L. Fraenkel et al., "Understanding patient preferences for the treatment of lupus nephritis with Adaptive Conjoint Analysis", MED CARE, 39(11), 2001, pp. 1203-1216
31. McMurray, RW
    Nonstandard and adjunctive medical therapies for systemic lupus erythematosus
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH
    
    R.W. McMurray, "Nonstandard and adjunctive medical therapies for systemic lupus erythematosus", ARTH RH ART, 45(1), 2001, pp. 86-100
32. Langford, CA
    Treatment of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: Where do we stand?
    ARTHRITIS AND RHEUMATISM
    
    C.A. Langford, "Treatment of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: Where do we stand?", ARTH RHEUM, 44(3), 2001, pp. 508-512
33. Gayraud, M; Guillevin, L; le Toumelin, P; Cohen, P; Lhote, F; Casassus, P; Jarrousse, B
    Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome - Analysis of four prospective trials including 278 patients
    ARTHRITIS AND RHEUMATISM
    
    M. Gayraud et al., "Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome - Analysis of four prospective trials including 278 patients", ARTH RHEUM, 44(3), 2001, pp. 666-675
34. Takaoka, T; Matsukawa, Y; Tomita, Y; Kitamura, N; Yamazaki, T; Takeuchi, J; Nishinarita, S; Sawada, U; Horie, T
    Development of erythroleukaemia after myelodysplastic syndrome in a patient with Wegener's granulomatosis
    ANNALS OF THE RHEUMATIC DISEASES
    
    T. Takaoka et al., "Development of erythroleukaemia after myelodysplastic syndrome in a patient with Wegener's granulomatosis", ANN RHEUM D, 60(9), 2001, pp. 899-900
35. Nossent, HC; Koldingsnes, W
    Long-term efficacy of azathioprine treatment for proliferative lupus nephritis
    RHEUMATOLOGY
    
    H.C. Nossent e W. Koldingsnes, "Long-term efficacy of azathioprine treatment for proliferative lupus nephritis", RHEUMATOLOG, 39(9), 2000, pp. 969-974
36. Jayne, D
    Evidence-based treatment of systemic vasculitis
    RHEUMATOLOGY
    
    D. Jayne, "Evidence-based treatment of systemic vasculitis", RHEUMATOLOG, 39(6), 2000, pp. 585-595
37. Halevy, D; Radhakrishnan, J
    Cyclosporin treatment of glomerular diseases
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    D. Halevy e J. Radhakrishnan, "Cyclosporin treatment of glomerular diseases", EXPERT OP I, 9(5), 2000, pp. 1053-1063
38. Gluck, O; Maricic, M
    Infusion therapies in rheumatic practice
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
    
    O. Gluck e M. Maricic, "Infusion therapies in rheumatic practice", JCR-J CLIN, 6(5), 2000, pp. 294-299
39. Mattix, H; Singh, AK
    Estrogen replacement therapy: implications for postmenopausal women with end-stage renal disease
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
    
    H. Mattix e A.K. Singh, "Estrogen replacement therapy: implications for postmenopausal women with end-stage renal disease", CURR OP NEP, 9(3), 2000, pp. 207-214
40. Balow, JE; Austin, HA
    Progress in the treatment of proliferative lupus nephritis
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
    
    J.E. Balow e H.A. Austin, "Progress in the treatment of proliferative lupus nephritis", CURR OP NEP, 9(2), 2000, pp. 107-115
41. Petri, M
    The egg and I: preserving fertility in systemic lupus erythematosus
    LUPUS
    
    M. Petri, "The egg and I: preserving fertility in systemic lupus erythematosus", LUPUS, 9(6), 2000, pp. 399-400
42. Blumenfeld, Z; Shapiro, D; Shteinberg, M; Avivi, I; Nahir, M
    Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy
    LUPUS
    
    Z. Blumenfeld et al., "Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy", LUPUS, 9(6), 2000, pp. 401-405
43. Meyers, KEC; Pfieffer, S; Lu, T; Kaplan, BS
    Genitourinary complications of systemic lupus erythematosus
    PEDIATRIC NEPHROLOGY
    
    K.E.C. Meyers et al., "Genitourinary complications of systemic lupus erythematosus", PED NEPHROL, 14(5), 2000, pp. 416-421
44. Niaudet, P
    Treatment of lupus nephritis in children
    PEDIATRIC NEPHROLOGY
    
    P. Niaudet, "Treatment of lupus nephritis in children", PED NEPHROL, 14(2), 2000, pp. 158-166
45. Kammer, GM; Mishra, N
    Systemic lupus erythematosus in the elderly
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
    
    G.M. Kammer e N. Mishra, "Systemic lupus erythematosus in the elderly", RHEUM DIS C, 26(3), 2000, pp. 475
46. Ortmann, RA; Klippel, JH
    Update on cyclophosphamide for systemic lupus erythematosus
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
    
    R.A. Ortmann e J.H. Klippel, "Update on cyclophosphamide for systemic lupus erythematosus", RHEUM DIS C, 26(2), 2000, pp. 363
47. Illei, GG; Klippel, JH
    Apheresis
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
    
    G.G. Illei e J.H. Klippel, "Apheresis", RHEUM DIS C, 26(1), 2000, pp. 63
48. Neumann-Andersen, G; Lindgren, S
    Involvement of the entire spinal cord and medulla oblongata in acute catastrophic-onset transverse myelitis in SLE
    CLINICAL RHEUMATOLOGY
    
    G. Neumann-Andersen e S. Lindgren, "Involvement of the entire spinal cord and medulla oblongata in acute catastrophic-onset transverse myelitis in SLE", CLIN RHEUMA, 19(2), 2000, pp. 156-160
49. Luqmani, RA
    Is it possible to offer evidence-based treatment for systemic vasculitis?
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
    
    R.A. Luqmani, "Is it possible to offer evidence-based treatment for systemic vasculitis?", SC J RHEUM, 29(4), 2000, pp. 211-215
50. Austin, HA; Balow, JE
    Treatment of lupus nephritis
    SEMINARS IN NEPHROLOGY
    
    H.A. Austin e J.E. Balow, "Treatment of lupus nephritis", SEM NEPHROL, 20(3), 2000, pp. 265-276
51. Balow, JE; Boumpas, DT; Austin, HA
    New prospects for treatment of lupus nephritis
    SEMINARS IN NEPHROLOGY
    
    J.E. Balow et al., "New prospects for treatment of lupus nephritis", SEM NEPHROL, 20(1), 2000, pp. 32-39
52. Tellier, P; Godeau, P
    Menopause and hormone replacement therapy.
    REVUE DE MEDECINE INTERNE
    
    P. Tellier e P. Godeau, "Menopause and hormone replacement therapy.", REV MED IN, 21(5), 2000, pp. 445-457
53. Ioannidis, JPA; Boki, KA; Katsorida, ME; Drosos, AA; Skopouli, FN; Boletis, JN; Moutsopoulos, HM
    Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide
    KIDNEY INTERNATIONAL
    
    J.P.A. Ioannidis et al., "Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide", KIDNEY INT, 57(1), 2000, pp. 258-264
54. Tomsic, M; Sifrer, F
    Acute respiratory distress syndrome in a polymyositis patient with the anti-Jo-1 antibody
    WIENER KLINISCHE WOCHENSCHRIFT
    
    M. Tomsic e F. Sifrer, "Acute respiratory distress syndrome in a polymyositis patient with the anti-Jo-1 antibody", WIEN KLIN W, 112(15-16), 2000, pp. 728-731
55. Daderian, AD; Chayasirisobhon, S
    An unusual case of multiple cranial nerve palsies in Wegener's granulomatosis
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
    
    A.D. Daderian e S. Chayasirisobhon, "An unusual case of multiple cranial nerve palsies in Wegener's granulomatosis", J NAT MED A, 92(9), 2000, pp. 455-457
56. Lehman, TJA; Onel, K
    Intermittent intravenous cyclophosphamide arrests progression of the renalchronicity index in childhood systemic lupus erythematosus
    JOURNAL OF PEDIATRICS
    
    T.J.A. Lehman e K. Onel, "Intermittent intravenous cyclophosphamide arrests progression of the renalchronicity index in childhood systemic lupus erythematosus", J PEDIAT, 136(2), 2000, pp. 243-247
57. Reinhold-Keller, E; Beuge, N; Latza, U; de Groot, K; Rudert, H; Nolle, B; Heller, M; Gross, WL
    An interdisciplinary approach to the care of patients with Wegener's granulomatosis - Long-term outcome in 155 patients
    ARTHRITIS AND RHEUMATISM
    
    E. Reinhold-Keller et al., "An interdisciplinary approach to the care of patients with Wegener's granulomatosis - Long-term outcome in 155 patients", ARTH RHEUM, 43(5), 2000, pp. 1021-1032
58. Ward, MM
    Changes in the incidence of end-stage renal disease due to lupus nephritis, 1982-1995
    ARCHIVES OF INTERNAL MEDICINE
    
    M.M. Ward, "Changes in the incidence of end-stage renal disease due to lupus nephritis, 1982-1995", ARCH IN MED, 160(20), 2000, pp. 3136-3140
59. Brogan, PA; Dillon, M
    The use of immunosuppressive and cytotoxic drugs in non-malignant disease
    ARCHIVES OF DISEASE IN CHILDHOOD
    
    P.A. Brogan e M. Dillon, "The use of immunosuppressive and cytotoxic drugs in non-malignant disease", ARCH DIS CH, 83(3), 2000, pp. 259-264
60. White, B; Moore, WC; Wigley, FM; Xiao, HQ; Wise, RA
    Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis
    ANNALS OF INTERNAL MEDICINE
    
    B. White et al., "Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis", ANN INT MED, 132(12), 2000, pp. 947
61. Venetz, JP; Rossert, J
    Microscopic polyangiitis.
    ANNALES DE MEDECINE INTERNE
    
    J.P. Venetz e J. Rossert, "Microscopic polyangiitis.", ANN MED IN, 151(3), 2000, pp. 193-198
62. Papo, T; Huong, DLT; Wiederkehr, JL; Woehl-Kremer, B; Bletry, O; Wechsler, B; Godeau, P; Piette, JC
    Etoposide in Wegener's granulomatosis
    RHEUMATOLOGY
    
    T. Papo et al., "Etoposide in Wegener's granulomatosis", RHEUMATOLOG, 38(5), 1999, pp. 473-475
63. Belmont, HM
    Lupus nephritis - Treatment issues
    BIODRUGS
    
    H.M. Belmont, "Lupus nephritis - Treatment issues", BIODRUGS, 11(1), 1999, pp. 7-19
64. Gross, WL; Trabandt, A
    Current aspects of the pathogenesis and therapy of Wegener's granulomatosis
    REVUE DU RHUMATISME
    
    W.L. Gross e A. Trabandt, "Current aspects of the pathogenesis and therapy of Wegener's granulomatosis", REV RHUM, 66(6), 1999, pp. 299-302
65. Van der Woude, FJ; Ferrario, F; D'Amico, G; Imbasciati, E; Roccatello, D; Fornasieri, A; Moriconi, L; Radice, A; Locatelli, F; Bordin, G; Montecucco, CM; Gregorini, G; Vendemia, F
    Renal involvement in ANCA-associated systemic vasculitis
    JOURNAL OF NEPHROLOGY
    
    F.J. Van der Woude et al., "Renal involvement in ANCA-associated systemic vasculitis", J NEPHROL, 12(2), 1999, pp. 105-128
66. Cameron, JS
    Lupus nephritis: an historical perspective 1968-1998
    JOURNAL OF NEPHROLOGY
    
    J.S. Cameron, "Lupus nephritis: an historical perspective 1968-1998", J NEPHROL, 12, 1999, pp. S29-S41
67. Nowack, R; Gobel, U; Klooker, P; Hergesell, O; Andrassy, K; Van der Woude, FJ
    Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: A pilot study in 11 patients with renal involvement
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    
    R. Nowack et al., "Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: A pilot study in 11 patients with renal involvement", J AM S NEPH, 10(9), 1999, pp. 1965-1971
68. Dooley, MA; Cosio, FG; Nachman, PH; Falkenhain, ME; Hogan, SL; Falk, RJ; Hebert, LA
    Mycophenolate mofetil therapy in lupus nephritis: Clinical observations
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    
    M.A. Dooley et al., "Mycophenolate mofetil therapy in lupus nephritis: Clinical observations", J AM S NEPH, 10(4), 1999, pp. 833-839
69. Cameron, JS
    Lupus nephritis
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    
    J.S. Cameron, "Lupus nephritis", J AM S NEPH, 10(2), 1999, pp. 413-424
70. Corzillius, M; Bae, SC
    Methodological issues of corticosteroid use in SLE clinical trials
    LUPUS
    
    M. Corzillius e S.C. Bae, "Methodological issues of corticosteroid use in SLE clinical trials", LUPUS, 8(8), 1999, pp. 692-697
71. Wallace, DJ
    Apheresis for lupus erythematosus
    LUPUS
    
    D.J. Wallace, "Apheresis for lupus erythematosus", LUPUS, 8(3), 1999, pp. 174-180
72. Slater, CA; Liang, MH; McCune, JW; Christman, GM; Laufer, MR
    Preserving ovarian function in patients receiving cyclophosphamide
    LUPUS
    
    C.A. Slater et al., "Preserving ovarian function in patients receiving cyclophosphamide", LUPUS, 8(1), 1999, pp. 3-10
73. Guillevin, L
    Treatment of classic polyarteritis nodosa in 1999
    NEPHROLOGY DIALYSIS TRANSPLANTATION
    
    L. Guillevin, "Treatment of classic polyarteritis nodosa in 1999", NEPH DIAL T, 14(9), 1999, pp. 2077-2079
74. Rennert, WP; Kala, UK; Jacobs, D; Goetsch, S; Verhaart, S
    Pulse cyclophosphamide for steroid-resistant focal segmental glomerulosclerosis
    PEDIATRIC NEPHROLOGY
    
    W.P. Rennert et al., "Pulse cyclophosphamide for steroid-resistant focal segmental glomerulosclerosis", PED NEPHROL, 13(2), 1999, pp. 113-116
75. Niaudet, P
    Management of lupus nephritis in children.
    ARCHIVES DE PEDIATRIE
    
    P. Niaudet, "Management of lupus nephritis in children.", ARCH PED, 6(12), 1999, pp. 1312-1321
76. Vena, GA; Cassano, N
    Immunosuppressive therapy in cutaneous vasculitis
    CLINICS IN DERMATOLOGY
    
    G.A. Vena e N. Cassano, "Immunosuppressive therapy in cutaneous vasculitis", CLIN DERMAT, 17(6), 1999, pp. 633-640
77. Covelli, M; Lapadula, G; Pipitone, V
    Cogan's syndrome: Unsuccessful outcome with early combination therapy
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    
    M. Covelli et al., "Cogan's syndrome: Unsuccessful outcome with early combination therapy", CLIN EXP RH, 17(4), 1999, pp. 479-483
78. Suwa, A; Hirakata, M; Satoh, S; Mimori, T; Utsumi, K; Inada, S
    Rheumatoid arthritis associated with methotrexate-induced pneumonitis: Improvement with i.v. cyclophosphamide therapy
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    
    A. Suwa et al., "Rheumatoid arthritis associated with methotrexate-induced pneumonitis: Improvement with i.v. cyclophosphamide therapy", CLIN EXP RH, 17(3), 1999, pp. 355-358
79. Baca, V; Lavalle, C; Garcia, R; Catalan, T; Sauceda, JM; Sanchez, G; Martinez, I; Ramirez, ML; Marquez, LM; Rojas, JC
    Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus
    JOURNAL OF RHEUMATOLOGY
    
    V. Baca et al., "Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus", J RHEUMATOL, 26(2), 1999, pp. 432-439
80. Deodhar, AA; Hockenedel, T; Bennett, RM
    Longitudinal involvement of the spinal cord in a patient with lupus related transverse myelitis
    JOURNAL OF RHEUMATOLOGY
    
    A.A. Deodhar et al., "Longitudinal involvement of the spinal cord in a patient with lupus related transverse myelitis", J RHEUMATOL, 26(2), 1999, pp. 446-449
81. Strand, V; Gladman, D; Isenberg, D; Petri, M; Smolen, J; Tugwell, P
    Outcome measures to be used in clinical trials in systemic lupus erythematosus
    JOURNAL OF RHEUMATOLOGY
    
    V. Strand et al., "Outcome measures to be used in clinical trials in systemic lupus erythematosus", J RHEUMATOL, 26(2), 1999, pp. 490-497
82. Lim, CS; Chin, HJ; Jung, YC; Kim, YS; Ahn, C; Han, JS; Kim, S; Lee, JS
    Prognostic factors of diffuse proliferative lupus nephritis
    CLINICAL NEPHROLOGY
    
    C.S. Lim et al., "Prognostic factors of diffuse proliferative lupus nephritis", CLIN NEPHR, 52(3), 1999, pp. 139-147
83. Austin, HA; Balow, JE
    Natural history and treatment of lupus nephritis
    SEMINARS IN NEPHROLOGY
    
    H.A. Austin e J.E. Balow, "Natural history and treatment of lupus nephritis", SEM NEPHROL, 19(1), 1999, pp. 2-11
84. Klein, M; Radhakrishnan, J; Appel, G
    Cyclosporine treatment of glomerular diseases
    ANNUAL REVIEW OF MEDICINE
    
    M. Klein et al., "Cyclosporine treatment of glomerular diseases", ANN R MED, 50, 1999, pp. 1-15
85. Langford, CA; Hoffman, GS
    Wegener's granulomatosis
    THORAX
    
    C.A. Langford e G.S. Hoffman, "Wegener's granulomatosis", THORAX, 54(7), 1999, pp. 629-637
86. Huong, DLT; Papo, T; Beaufils, H; Wechsler, B; Bletry, O; Baumelou, A; Godeau, P; Piette, JC
    Renal involvement in systemic lupus erythematosus - A study of 180 patients from a single center
    MEDICINE
    
    D.L.T. Huong et al., "Renal involvement in systemic lupus erythematosus - A study of 180 patients from a single center", MEDICINE, 78(3), 1999, pp. 148-166
87. Jonsson, CA; Svensson, L; Carlsten, H
    Beneficial effect of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil on survival and severity of glomerulonephritis in systemic lupus erythematosus (SLE)-prone MRLlpr/lpr mice
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    
    C.A. Jonsson et al., "Beneficial effect of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil on survival and severity of glomerulonephritis in systemic lupus erythematosus (SLE)-prone MRLlpr/lpr mice", CLIN EXP IM, 116(3), 1999, pp. 534-541
88. Hellmich, B; Schanbel, A; Gross, WL
    Granulocyte colony-stimulating factor treatment for cyclophosphamide-induced severe neutropenia in Wegener's granulomatosis
    ARTHRITIS AND RHEUMATISM
    
    B. Hellmich et al., "Granulocyte colony-stimulating factor treatment for cyclophosphamide-induced severe neutropenia in Wegener's granulomatosis", ARTH RHEUM, 42(8), 1999, pp. 1752-1756
89. SULLIVAN EJ; HOFFMAN GS
    WEGENERS GRANULOMATOSIS
    Seminars in respiratory and critical care medicine
    
    E.J. Sullivan e G.S. Hoffman, "WEGENERS GRANULOMATOSIS", Seminars in respiratory and critical care medicine, 19(1), 1998, pp. 13-25
90. Boumpas, DT; Balow, JE
    Outcome criteria for lupus nephritis trials: A critical overview
    LUPUS
    
    D.T. Boumpas e J.E. Balow, "Outcome criteria for lupus nephritis trials: A critical overview", LUPUS, 7(9), 1998, pp. 622-629
91. Illei, GG; Klippel, JH
    Novel approaches in the treatment of lupus nephritis
    LUPUS
    
    G.G. Illei e J.H. Klippel, "Novel approaches in the treatment of lupus nephritis", LUPUS, 7(9), 1998, pp. 644-648
92. GUILLEVIN L
    SYNCHRONIZATION OF PLASMA-EXCHANGE AND ADJUVANT TREATMENTS
    Transfusion science
    
    L. Guillevin, "SYNCHRONIZATION OF PLASMA-EXCHANGE AND ADJUVANT TREATMENTS", Transfusion science, 19(1), 1998, pp. 27-33
93. KLIPPEL JH
    INDICATIONS FOR, AND USE OF, CYTOTOXIC AGENTS IN SLE
    Bailliere's clinical rheumatology
    
    J.H. Klippel, "INDICATIONS FOR, AND USE OF, CYTOTOXIC AGENTS IN SLE", Bailliere's clinical rheumatology, 12(3), 1998, pp. 511-527
94. Gillis, S; Eldor, A
    Immune thrombocytopenic purpura in adults: clinical aspects
    BAILLIERES CLINICAL HAEMATOLOGY
    
    S. Gillis e A. Eldor, "Immune thrombocytopenic purpura in adults: clinical aspects", BAIL CLIN H, 11(2), 1998, pp. 361-372
95. BRUNKHORST R
    CLINICAL IMMUNOADSORPTION, HANNOVER, GERMANY, 28 FEBRUARY 1 MARCH 1997
    Nephrology, dialysis, transplantation
    
    R. Brunkhorst, "CLINICAL IMMUNOADSORPTION, HANNOVER, GERMANY, 28 FEBRUARY 1 MARCH 1997", Nephrology, dialysis, transplantation, 13(1), 1998, pp. 222-224
96. MARMONT AM
    STEM-CELL TRANSPLANTATION FOR SEVERE AUTOIMMUNE-DISEASES - PROGRESS AND PROBLEMS
    Haematologica
    
    A.M. Marmont, "STEM-CELL TRANSPLANTATION FOR SEVERE AUTOIMMUNE-DISEASES - PROGRESS AND PROBLEMS", Haematologica, 83(8), 1998, pp. 733-743
97. RICHMOND R; MCMILLAN TW; LUQMANI RA
    OPTIMIZATION OF CYCLOPHOSPHAMIDE THERAPY IN SYSTEMIC VASCULITIS
    Clinical pharmacokinetics
    
    R. Richmond et al., "OPTIMIZATION OF CYCLOPHOSPHAMIDE THERAPY IN SYSTEMIC VASCULITIS", Clinical pharmacokinetics, 34(1), 1998, pp. 79-90
98. WECHSLER B; HUONG DL; VAUTHIERBROUZES D; LEFEBVRE G; GOMPEL A; PIETTE JC
    CAN WE ADVISE OVULATION INDUCTION IN PATIENTS WITH SLE
    Scandinavian journal of rheumatology
    
    B. Wechsler et al., "CAN WE ADVISE OVULATION INDUCTION IN PATIENTS WITH SLE", Scandinavian journal of rheumatology, 1998, pp. 53-59
99. ANDREOLI SP
    RENAL MANIFESTATIONS OF SYSTEMIC-DISEASES
    Seminars in nephrology
    
    S.P. Andreoli, "RENAL MANIFESTATIONS OF SYSTEMIC-DISEASES", Seminars in nephrology, 18(3), 1998, pp. 270-279
100. KOLDINGSNES W; GRAN JT; OMDAL R; HUSBY G
     WEGENERS GRANULOMATOSIS - LONG-TERM FOLLOW-UP OF PATIENTS TREATED WITH PULSE CYCLOPHOSPHAMIDE
     British journal of rheumatology
     
     W. Koldingsnes et al., "WEGENERS GRANULOMATOSIS - LONG-TERM FOLLOW-UP OF PATIENTS TREATED WITH PULSE CYCLOPHOSPHAMIDE", British journal of rheumatology, 37(6), 1998, pp. 659-664